natgillin/translations-raw huggingface dataset:
Blood pressure-lowering medicines:
Zdravila za zniževanje krvnega tlaka:
ABILIFY may increase the effect of medicines used to lower the blood pressure.
ABILIFY lahko poveča učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
Taking ABILIFY with some medicines may need to change your dose of ABILIFY.
Med jemanjem zdravila ABILIFY z nekaterimi zdravili utegne biti potrebna sprememba odmerka zdravila ABILIFY.
Medicines to correct heart rhythm Antidepressants or herbal remedy used to treat depression and anxiety Antifungal agents Certain medicines to treat HIV infection Anticonvulsants used to treat epilepsy
Posebno pomembno je, da svojemu zdravniku poveste za: zdravila proti motnjam srčnega ritma, antidepresivna zdravila ali zeliščne pripravke proti depresiji in tesnobnosti, zdravila proti glivicam, določena zdravila za zdravljenje okužbe s HIV, antiepileptična zdravila (zdravila za zdravljenje epilepsije).
Taking ABILIFY with food and drink ABILIFY can be taken regardless of meals.
Jemanje zdravila ABILIFY skupaj s hrano in pijačo ABILIFY lahko jemljete ne glede na obroke.
Alcohol should be avoided when taking ABILIFY.
Med jemanjem zdravila ABILIFY se morate izogibati alkoholu.
Pregnancy and breast-feeding You should not take ABILIFY if you are pregnant unless you have discussed this with your doctor.
Nosečnost in dojenje Če ste noseči, ne smete jemati zdravila ABILIFY, razen če ste se tako dogovorili z zdravnikom.
Be sure to tell your doctor immediately if you are pregnant, think you may be pregnant, or if you are planning to become pregnant.
Zdravniku morate takoj povedati, če ste noseči, če mislite, da ste zanosili, ali če nameravate zanositi.
Breast-feeding mothers should not take ABILIFY.
Doječe matere ne smejo jemati zdravila ABILIFY.
Driving and using machines Do not drive or use any tools or machines, until you know how ABILIFY affects you.
Vpliv na sposobnost upravljanja vozil in strojev Ne vozite in ne upravljajte orodij ali strojev, dokler ne veste, kako ABILIFY vpliva na vas.
Important information about some of the ingredients of ABILIFY If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Pomembne informacije o nekaterih sestavinah zdravila ABILIFY Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se pred uporabo tega zdravila posvetujte z zdravnikom.
HOW TO TAKE ABILIFY
KAKO JEMATI ZDRAVILO ABILIFY
Always take ABILIFY exactly as your doctor has told you.
Pri jemanju zdravila ABILIFY natančno upoštevajte zdravnikova navodila.
However your doctor may prescribe a lower or higher dose to a maximum of 30 mg once a day.
Običajni odmerek je 15 mg enkrat na dan, toda vaš zdravnik vam lahko predpiše odmerek, ki je manjši ali večji, do največ 30 mg enkrat na dan.
If you have the impression that the effect of ABILIFY is too strong or too weak, talk to your doctor or pharmacist.
Če menite, da je učinek zdravila ABILIFY premočan ali prešibak, se posvetujte z zdravnikom ali s farmacevtom.
Try to take the ABILIFY tablet at the same time each day.
Prizadevajte si, da bi tableto ABILIFY vzeli vsak dan ob istem času.
Always take the tablet with water and swallow it whole.
Ni pomembno, ali jo vzamete s hrano ali brez nje, vedno pa jo vzemite z vodo in jo pogoltnite celo.
138 Even if you feel better, do not alter or discontinue the daily dose of ABILIFY without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila ABILIFY, ne da bi se prej posvetovali z zdravnikom.
If you take more ABILIFY than you should If you realise you have taken more ABILIFY tablets than your doctor has recommended (or if someone else has taken some of your ABILIFY tablets), contact your doctor right away.
145 Če ste vzeli večji odmerek zdravila ABILIFY, kot bi smeli Če ugotovite, da ste vzeli več tablet ABILIFY, kot vam je priporočil zdravnik (ali če je vaše tablete ABILIFY vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
If you forget to take ABILIFY If you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.
Če ste pozabili vzeti zdravilo ABILIFY Če ste pozabili vzeti odmerek, ga vzemite takoj, ko se spomnite, vendar ne vzemite dveh odmerkov na en dan.
Like all medicines, ABILIFY can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi ABILIFY neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Common side effects (greater than 1 in 100, less than 1 in 10 patients) Uncontrollable twitching or jerking movements, headache, tiredness, nausea, vomiting, an uncomfortable feeling in the stomach, constipation, increased production of saliva, light-headedness, trouble sleeping, restlessness, feeling anxious, sleepiness, shaking and blurred vision.
Pogosti neželeni učinki (pri več kot 1 od 100, manj kot 1 od 10 bolnikov) Nenadzorovano trzanje ali sunkoviti gibi, glavobol, utrujenost, občutek siljenja na bruhanje, bruhanje, neprijeten občutek v želodcu, zaprtje, močnejše izločanje sline, omotičnost, težave s spanjem, nemir, občutek tesnobe, zaspanost, tresenje in zamegljen vid.
Uncommon side effects (greater than 1 in 1,000, less than 1 in 100 patients) Some people may feel dizzy, especially when getting up from a lying or sitting position, or may experience a fast heart rate.
Občasni neželeni učinki (pri več kot 1 od 1. 000, manj kot 1 od 100 bolnikov) Nekateri ljudje se počutijo vrtoglavi, zlasti če vstanejo iz ležečega ali sedečega položaja, ali občutijo hitro bitje srca.
Some people may feel depressed.
Pri posameznikih se lahko pojavi depresija.
Changes in the levels of some blood cells; unusual heart beat, sudden unexplained death, heart attack; allergic reaction (e. g. swelling in the mouth, tongue, face and throat, itching, rash); high blood sugar, onset or worsening of diabetes, ketoacidosis (ketones in the blood and urine) or coma, low sodium level in the blood; weight gain, weight loss, anorexia; nervousness, agitation, feeling anxious; thoughts of suicide, suicide attempt and suicide; speech disorder, seizure, combination of fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate; fainting, high blood pressure, blockage of a blood vessel by a blood clot formed elsewhere in the body; spasm of the muscles around the voice box, accidental inhalation of food with risk of pneumonia, difficulty in swallowing; inflammation of the pancreas; inflammation of the liver, yellowing of the skin and white part of eyes, reports of abnormal liver test values, abdominal and stomach discomfort, diarrhoea; skin rash and sensitivity to light, unusual hair loss or thinning, excessive sweating; stiffness or cramps, muscle pain, weakness; involuntary loss of urine, difficulty in passing urine; prolonged and/ or painful erection; difficulty controlling core body temperature or overheating, chest pain, and swelling of hands, ankles or feet.
Drugi redki neželeni učinki Spremembe števila nekaterih krvnih celic; nenavaden srčni utrip, nenadna nepojasnjena smrt, srčni infarkt; alergijska reakcija (npr. oteklost ust, jezika, obraza in žrela, srbenje, izpuščaj); visok krvni sladkor, pojav sladkorne bolezni (diabetesa) ali njeno poslabšanje, ketoacidoza (ketoni v krvi in urinu) ali koma, nizka koncentracija natrija v krvi; povečanje telesne mase, hujšanje, neješčnost; živčnost, vznemirjenost, občutek tesnobe; razmišljanje o samomoru; poskus samomora in samomor; motnje govora, epileptični napad, kombinacija zvišane telesne temperature, togosti mišic, hitrega dihanja, znojenja, zmanjšane stopnje zavesti in nenadne spremembe krvnega tlaka ter hitrosti srčnega utripa, omedlevica; visok krvni tlak, zamašitev krvne žile s krvnim strdkom, nastalim drugje v telesu; krči mišic v grlu, naključno vdihanje hrane s tveganjem za pljučnico, težave pri požiranju; vnetje trebušne slinavke; vnetje jeter, porumenelost kože in očesnih beločnic, primeri nenormalnih izvidov laboratorijskih jetrnih preiskav, bolečine v trebuhu in želodcu, driska; osip po koži in občutljivost za svetlobo, neobičajno izpadanje ali razredčenje las oz. dlak, prekomerno potenje; togost ali krči, bolečine v mišicah, šibkost; nehotno uhajanje urina, težave pri odvajanju urina; dolgotrajna in/ ali boleča erekcija; težave z uravnavanjem jedrne telesne temperature ali pregretje, bolečina v prsih in zatekanje rok, gležnjev ali stopal.
In elderly patients with dementia, more fatal cases have been reported while taking aripiprazole.
Pri starejših bolnikih z demenco je bilo med jemanjem aripiprazola opisanih več smrtnih primerov.
HOW TO STORE ABILIFY
SHRANJEVANJE ZDRAVILA ABILIFY
Do not use ABILIFY after the expiry date which is stated on the blister and on the carton.
Zdravila ABILIFY ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na pretisnem omotu in na škatli.
139 Store in the original package in order to protect from moisture.
146 Shranjujte v originalni ovojnini za zagotovitev zaščite pred vlago.
What ABILIFY contains The active substance is aripiprazole.
Kaj vsebuje zdravilo ABILIFY Zdravilna učinkovina je aripiprazol.
The other ingredients are lactose monohydrate, maize starch, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate, indigo carmine aluminium lake (E132).
Pomožne snovi so laktoza monohidrat, koruzni škrob, mikrokristalna celuloza, hidroksipropilceluloza, magnezijev stearat, indigotin (E132).
What ABILIFY looks like and contents of the pack ABILIFY 5 mg tablets are rectangular and blue, marked with A-007 and 5 on one side.
Izgled zdravila ABILIFY in vsebina pakiranja Tablete ABILIFY 5 mg so pravokotne in modre, označene z A- 007 in 5 na eni strani.
They are supplied in perforated unit dose blisters packed in cartons containing 14, 28, 49, 56, or 98 tablets.
Na voljo so v perforiranih pretisnih omotih za enkratni odmerek v škatlah, ki vsebujejo po 14, 28, 49, 56 ali 98 tablet.
Marketing Authorisation Holder Otsuka Pharmaceutical Europe Ltd.
Imetnik dovoljenja za promet z zdravilom Otsuka Pharmaceutical Europe Ltd.
Manufacturer Bristol-Myers Squibb S. r. l.
Izdelovalec Bristol- Myers Squibb S. r. l.
Contrada Fontana del Ceraso I-03012 Anagni-Frosinone - Italy
Contrada Fontana del Ceraso I- 03012 Anagni- Frosinone - Italija
140 Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
147 Eesti Österreich BRISTOL- MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
INFORMATION FOR THE USER
148 NAVODILO ZA UPORABO
142 Tell your doctor immediately if you suffer from muscle stiffness or inflexibility with high fever, sweating, altered mental status, or very rapid or irregular heart beat.
149 Če se pojavi togost ali neprožnost mišic z zvišano telesno temperaturo, znojenje, sprememba duševnega stanja ali zelo hiter ali nepravilen srčni utrip, o tem nemudoma obvestite svojega zdravnika.
143 Even if you feel better, do not alter or discontinue the daily dose of ABILIFY without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila ABILIFY, ne da bi se prej posvetovali z zdravnikom.
If you take more ABILIFY than you should If you realise you have taken more ABILIFY tablets than your doctor has recommended (or if someone else has taken some of your ABILIFY tablets), contact your doctor right away.
150 Če ste vzeli večji odmerek zdravila ABILIFY, kot bi smeli Če ugotovite, da ste vzeli več tablet ABILIFY, kot vam je priporočil zdravnik (ali če je vaše tablete ABILIFY vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
144 Store in the original package in order to protect from moisture.
151 Shranjujte v originalni ovojnini za zagotovitev zaščite pred vlago.
The other ingredients are lactose monohydrate, maize starch, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate, red iron oxide (E172).
Pomožne snovi so laktoza monohidrat, koruzni škrob, mikrokristalna celuloza, hidroksipropilceluloza, magnezijev stearat, rdeč železov oksid (E172).
What ABILIFY looks like and contents of the pack ABILIFY 10 mg tablets are rectangular and pink, marked with A-008 and 10 on one side.
Izgled zdravila ABILIFY in vsebina pakiranja Tablete ABILIFY 10 mg so pravokotne in roza, označene z A- 008 in 10 na eni strani.
145 Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
152 Eesti Österreich BRISTOL- MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
INFORMATION FOR THE USER
153 NAVODILO ZA UPORABO
147 Tell your doctor immediately if you suffer from muscle stiffness or inflexibility with high fever, sweating, altered mental status, or very rapid or irregular heart beat.
154 Če se pojavi togost ali neprožnost mišic z zvišano telesno temperaturo, znojenje, sprememba duševnega stanja ali zelo hiter ali nepravilen srčni utrip, o tem nemudoma obvestite svojega zdravnika.
148 Even if you feel better, do not alter or discontinue the daily dose of ABILIFY without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila ABILIFY, ne da bi se prej posvetovali z zdravnikom.
If you take more ABILIFY than you should If you realise you have taken more ABILIFY tablets than your doctor has recommended (or if someone else has taken some of your ABILIFY tablets), contact your doctor right away.
155 Če ste vzeli večji odmerek zdravila ABILIFY, kot bi smeli Če ugotovite, da ste vzeli več tablet ABILIFY, kot vam je priporočil zdravnik (ali če je vaše tablete ABILIFY vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
149 Store in the original package in order to protect from moisture.
156 Shranjujte v originalni ovojnini za zagotovitev zaščite pred vlago.
The other ingredients are lactose monohydrate, maize starch, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate, yellow iron oxide (E172).
Pomožne snovi so laktoza monohidrat, koruzni škrob, mikrokristalna celuloza, hidroksipropilceluloza, magnezijev stearat, rumen železov oksid (E172).
What ABILIFY looks like and contents of the pack ABILIFY 15 mg tablets are round and yellow, marked with A-009 and 15 on one side.
Izgled zdravila ABILIFY in vsebina pakiranja Tablete ABILIFY 15 mg so okrogle in rumene, označene z A- 009 in 15 na eni strani.
150 Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
157 Eesti Österreich BRISTOL- MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
INFORMATION FOR THE USER
158 NAVODILO ZA UPORABO
152 Tell your doctor immediately if you suffer from muscle stiffness or inflexibility with high fever, sweating, altered mental status, or very rapid or irregular heart beat.
159 Če se pojavi togost ali neprožnost mišic z zvišano telesno temperaturo, znojenje, sprememba duševnega stanja ali zelo hiter ali nepravilen srčni utrip, o tem nemudoma obvestite svojega zdravnika.
153 Even if you feel better, do not alter or discontinue the daily dose of ABILIFY without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila ABILIFY, ne da bi se prej posvetovali z zdravnikom.
If you take more ABILIFY than you should If you realise you have taken more ABILIFY tablets than your doctor has recommended (or if someone else has taken some of your ABILIFY tablets), contact your doctor right away.
160 Če ste vzeli večji odmerek zdravila ABILIFY, kot bi smeli Če ugotovite, da ste vzeli več tablet ABILIFY, kot vam je priporočil zdravnik (ali če je vaše tablete ABILIFY vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
154 Store in the original package in order to protect from moisture.
161 Shranjujte v originalni ovojnini za zagotovitev zaščite pred vlago.
What ABILIFY looks like and contents of the pack ABILIFY 30 mg tablets are round and pink, marked with A-011 and 30 on one side.
Izgled zdravila ABILIFY in vsebina pakiranja Tablete ABILIFY 30 mg so okrogle in roza, označene z A- 011 in 30 na eni strani.
155 Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
162 Eesti Österreich BRISTOL- MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
INFORMATION FOR THE USER
163 NAVODILO ZA UPORABO
157 Tell your doctor immediately if you suffer from muscle stiffness or inflexibility with high fever, sweating, altered mental status, or very rapid or irregular heart beat.
164 Če se pojavi togost ali neprožnost mišic z zvišano telesno temperaturo, znojenje, sprememba duševnega stanja ali zelo hiter ali nepravilen srčni utrip, o tem nemudoma obvestite svojega zdravnika.
Important information about some of the ingredients of ABILIFY Patients who cannot take phenylalanine should note that ABILIFY orodispersible tablets contain aspartame, which is a source of phenylalanine.
Pomembne informacije o nekaterih sestavinah zdravila ABILIFY Bolniki, ki ne smejo uživati fenilalanina, se morajo zavedati, da orodisperzibilne tablete ABILIFY vsebujejo aspartam, ki je vir fenilalanina.
Try to take the ABILIFY orodispersible tablet at the same time each day.
Prizadevajte si, da bi orodisperzibilno tableto ABILIFY vzeli vsak dan ob istem času.
158 Do not open the blister until ready to administer.
165 Pretisnega omota ne odprite, dokler niste pripravljeni, da zdravilo zaužijete.
If you take more ABILIFY than you should If you realise you have taken more ABILIFY orodispersible tablets than your doctor has recommended (or if someone else has taken some of your ABILIFY orodispersible tablets), contact your doctor right away.
Če ste vzeli večji odmerek zdravila ABILIFY, kot bi smeli Če ugotovite, da ste vzeli več orodisperzibilnih tablet ABILIFY, kot vam je priporočil zdravnik (ali če je vaše orodisperzibilne tablete ABILIFY vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
Changes in the levels of some blood cells; unusual heart beat, sudden unexplained death, heart attack; allergic reaction (e. g. swelling in the mouth, tongue, face and throat, itching, rash); high blood sugar, onset or worsening of diabetes, ketoacidosis (ketones in the blood and urine) or coma, low sodium level in the blood; weight gain, weight loss, anorexia; nervousness, agitation, feeling anxious; thoughts of suicide, suicide attempt and suicide; speech disorder, seizure, combination of fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate; fainting, high blood pressure, blockage of a blood vessel by a blood clot formed elsewhere in the body; spasm of the muscles around the voice box, accidental inhalation of food with risk of pneumonia, difficulty in swallowing; inflammation of the pancreas; inflammation of the liver, yellowing of the skin and white part of eyes, reports of abnormal liver test values, abdominal and stomach discomfort, diarrhoea; skin rash and sensitivity to light, unusual hair loss or thinning, excessive sweating; stiffness or cramps, muscle pain, weakness; involuntary loss of urine, difficulty in passing urine; prolonged and/ or painful erection; difficulty controlling core body temperature or overheating, chest pain, and swelling of hands, ankles or feet.
Drugi redki neželeni učinki Spremembe števila nekaterih krvnih celic; nenavaden srčni utrip, nenadna nepojasnjena smrt, srčni infarkt; alergijska reakcija (npr. oteklost ust, jezika, obraza in žrela, srbenje, izpuščaj), visok krvni sladkor, pojav sladkorne bolezni (diabetesa) ali njeno poslabšanje, ketoacidoza (ketoni v krvi in urinu) ali koma, nizka koncentracija natrija v krvi; povečanje telesne mase, hujšanje, neješčnost; živčnost, vznemirjenost, občutek tesnobe; razmišljanje o samomoru; poskus samomora in samomor; motnje govora, epileptični napad, kombinacija zvišane telesne temperature, togosti mišic, hitrega dihanja, znojenja, zmanjšane stopnje zavesti in nenadne spremembe krvnega tlaka ter hitrosti srčnega utripa, omedlevica; visok krvni tlak, zamašitev krvne žile s krvnim strdkom, nastalim drugje v telesu; krči mišic v grlu, naključno vdihanje hrane s tveganjem za pljučnico, težave pri požiranju; vnetje trebušne slinavke; vnetje jeter, porumenelost kože in očesnih beločnic, primeri nenormalnih izvidov laboratorijskih jetrnih preiskav, bolečine v trebuhu in želodcu, driska; osip po koži in občutljivost za svetlobo, neobičajno izpadanje ali razredčenje las oz. dlak, prekomerno potenje; togost ali krči, bolečine v mišicah, šibkost; nehotno uhajanje urina, težave pri odvajanju urina; dolgotrajna in/ ali boleča erekcija; težave z uravnavanjem jedrne telesne temperature ali pregretje, bolečina v prsih in zatekanje rok, gležnjev ali stopal.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
166 Če kateri koli neželeni učinek postane resen ali če opazite kateri koli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
The other ingredients are calcium silicate, croscarmellose sodium, crospovidone, silicon dioxide, xylitol, microcrystalline cellulose, aspartame, acesulfame potassium, vanilla flavour, tartaric acid, magnesium stearate, red iron oxide (E172).
Pomožne snovi so kalcijev silikat, premreženi natrijev karmelozat, krospovidon, silicijev dioksid, ksilitol, mikrokristalna celuloza, aspartam, kalcijev acesulfamat, aroma vanilije, vinska kislina, magnezijev stearat, rdeč železov oksid (E172).
What ABILIFY looks like and contents of the pack ABILIFY 10 mg orodispersible tablets are round and pink, marked with "A" over "640" on one side and 10 on the other.
Izgled zdravila ABILIFY in vsebina pakiranja Orodisperzibilne tablete so okrogle oblike in roza barve, označene z "A" nad "640" na eni strani in 10 na drugi.
They are supplied in perforated unit dose blisters packed in cartons containing 14, 28, or 49 orodispersible tablets.
Na voljo so v perforiranih pretisnih omotih za enkratni odmerek, pakiranih v škatlah po 14, 28 ali 49 orodisperzibilnih tablet.
Č eská republika BRISTOL-MYERS SQUIBB SPOL.
167 Česká republika BRISTOL- MYERS SQUIBB SPOL.
This leaflet was last approved in
168 Navodilo je bilo odobreno
161 Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
INFORMATION FOR THE USER
169 NAVODILO ZA UPORABO
163 Tell your doctor immediately if you suffer from muscle stiffness or inflexibility with high fever, sweating, altered mental status, or very rapid or irregular heart beat.
170 Če se pojavi togost ali neprožnost mišic z zvišano telesno temperaturo, znojenje, sprememba duševnega stanja ali zelo hiter ali nepravilen srčni utrip, o tem nemudoma obvestite svojega zdravnika.
164 Do not open the blister until ready to administer.
171 Pretisnega omota ne odprite, dokler niste pripravljeni, da zdravilo zaužijete.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
172 Če kateri koli neželeni učinek postane resen ali če opazite kateri koli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
The other ingredients are calcium silicate, croscarmellose sodium, crospovidone, silicon dioxide, xylitol, microcrystalline cellulose, aspartame, acesulfame potassium, vanilla flavour, tartaric acid, magnesium stearate, yellow iron oxide (E172).
Pomožne snovi so kalcijev silikat, premreženi natrijev karmelozat, krospovidon, silicijev dioksid, ksilitol, mikrokristalna celuloza, aspartam, kalcijev acesulfamat, aroma vanilije, vinska kislina, magnezijev stearat, rumen železov oksid (E172).
What ABILIFY looks like and contents of the pack ABILIFY 15 mg orodispersible tablets are round and yellow, marked with "A" over "641" on one side and 15 on the other.
Izgled zdravila ABILIFY in vsebina pakiranja Orodisperzibilne tablete so okrogle oblike in rumene barve, označene z "A" nad "641" na eni strani in 15 na drugi.